MecStat^®

Fetal exposure to drugs and alcohol has been linked to long-term health problems in newborns. Since its launch by USDTL in 1991, the MecStat^® meconium test has offered a fast and reliable method for the detection of fetal drug and alcohol exposure and the opportunity to provide appropriate treatment and intervention. MecStat^® features include:

Simple, non-invasive collection of a meconium sample, eliminating the need to collect a blood or urine specimen from a newborn
Proprietary meconium extraction process and GC/MS analysis
A 20-week gestational detection window
Results in 48 hours or less for rapid healthcare treatment and planning for both mother and child.
A fetal alcohol exposure assay measuring meconium concentrations of fatty acid ethyl esters, the non-oxidative metabolites formed from ethanol and fatty acids.
The long-standing reputation as the gold standard for diagnosing fetal alcohol and drug exposure
Available as a 5-, 7-, 9-, 12- and 13-drug panel.
Ethanol available as add-on to any profile.